Effect of respiratory syncytial virus on the growth of hepatocellular carcinoma cell-lines

Down-modulation of Bis reduces the invasive ability of glioma cells induced by TPA, through NF-κB mediated activation of MMP-9

(2014) Young Dae Lee et al.   BMB Reports

PEP-1-HO-1 prevents MPTP-induced degeneration of dopaminergic neurons in a Parkinson's disease mouse model

(2014) Jong Kyu Youn et al.   BMB Reports

Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer

(2013) Jeong Heo et al.   NATURE MEDICINE

The Oncolytic Effect of Respiratory Syncytial Virus (RSV) in Human Skin Cancer Cell Line, A431

(2013) Vahid Salimi et al.   Iranian Red Crescent Medical Journal

PEP-1-p18 prevents neuronal cell death by inhibiting oxidative stress and Bax expression

(2012) Duk-Soo Kim et al.   BMB Reports

FGF-2 inhibits TNF-α mediated apoptosis through up-regulation of Bcl2-A1 and Bcl-xL in ATDC5 cells

(2012) Hey-Ryun Kim et al.   BMB Reports

Hepatocellular carcinoma

(2012) Alejandro Forner et al.   LANCET

Oncolytic virotherapy

(2012) Stephen J Russell et al.   NATURE BIOTECHNOLOGY

Baculovirus-based Vaccine Displaying Respiratory Syncytial Virus Glycoprotein Induces Protective Immunity against RSV Infection without Vaccine-Enhanced Disease

(2012) Sol Kim et al.   Immune Network

Current progress on development of respiratory syncytial virus vaccine

(2011) Jun Chang   BMB Reports

Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense

(2011) Ibtissam Echchgadda et al.   BMC CANCER

Sequential Therapy With JX-594, A Targeted Oncolytic Poxvirus, Followed by Sorafenib in Hepatocellular Carcinoma: Preclinical and Clinical Demonstration of Combination Efficacy

(2011) Jeong Heo et al.   MOLECULAR THERAPY

Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and Immunology

(2010) J. S. Tregoning et al.   CLINICAL MICROBIOLOGY REVIEWS

Anticancer oncolytic activity of respiratory syncytial virus

(2009) I Echchgadda et al.   CANCER GENE THERAPY

The Targeted Oncolytic Poxvirus JX-594 Demonstrates Antitumoral, Antivascular, and Anti-HBV Activities in Patients With Hepatocellular Carcinoma

(2008) Ta-Chiang Liu et al.   MOLECULAR THERAPY